Stockscreener 앱 받기
98.22
2.66%
-2.735
전일 마감가:
$100.96
열려 있는:
$99.6
하루 거래량:
79,616
Relative Volume:
0.19
시가총액:
$3.29B
수익:
$560.03M
순이익/손실:
$-150.66M
주가수익비율:
-20.21
EPS:
-4.86
순현금흐름:
$-87.43M
1주 성능:
-4.78%
1개월 성능:
-5.95%
6개월 성능:
+58.24%
1년 성능:
-12.33%
1일 변동 폭
$97.60
$100.08
1주일 범위
$97.60
$104.12
52주 변동 폭
$55.92
$128.52
Irhythm Technologies Inc Stock (IRTC) Company Profile
명칭
Irhythm Technologies Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
IRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
98.21 | 3.29B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
129.19 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.72 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
337.71 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.48 | 105.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.50 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Technologies Inc 주식(IRTC)의 최신 뉴스
Holter Monitoring System Market to Reach $1.91 Bn by 2034 | Miniaturization, Telehealth & Patient-Centric Innovations Fuel Growth - Global Banking | Finance | Review
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 | IRTC Stock News - GuruFocus
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times
iRhythm Technologies Announces Third Quarter 2024 Financial Results - ADVFN
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability | IRTC Stock News - GuruFocus
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability - The Globe and Mail
SEC Form DEF 14A filed by iRhythm Technologies Inc. - Quantisnow
Turing Medical names Kevin King as president and CEO - MSN
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer - 01net
Turing Medical Taps ex-iRhythm CEO Kevin King as Chief Exec - Medical Product Outsourcing
Turing Medical Names Transformative Med Tech Leader Kevin King a - GuruFocus
iRhythm Technologies (IRTC) Price Target Lowered by Truist Amid Market Uncertainties | IRTC Stock News - GuruFocus
Truist Cuts Price Target on iRhythm Technologies to $120 From $145, Keeps Buy Rating - marketscreener.com
3 Reasons IRTC is Risky and 1 Stock to Buy Instead - Yahoo Finance
Q4 Patient Monitoring Earnings Review: First Prize Goes To Masimo (NASDAQ:MASI) - Barchart.com
1 Small-Cap Stock Worth Your Attention and 2 to Question - Yahoo Finance
Cardiac Monitoring Devices Market Trends | Wearable & Remote - openPR.com
iRhythm Technologies, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights – IRTC - ACCESS Newswire
When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit? - Yahoo Finance
Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt? - simplywall.st
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Tempus AI Surges 43% YTD: Is It The Right Time To Invest In The Stock? - Barchart.com
Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? - Yahoo
iRhythm data highlights benefits of Zio long-term heart monitoring - MassDevice
(IRTC) Trading Advice - news.stocktradersdaily.com
iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection - Diagnostic and Interventional Cardiology
New studies challenge efficacy of short-term heart monitors - Investing.com
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection - TradingView
Major Study Reveals Critical Flaw in Traditional Heart Monitoring: 64% of Arrhythmias Missed - Stock Titan
Commit To Buy iRhythm Technologies At $75, Earn 8.6% Annualized Using Options - Nasdaq
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against iRhythm Technologies, Inc. - PR Newswire
UPCOMING IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
3 Healthcare Stocks in the Doghouse - Yahoo Finance
(IRTC) Trading Signals - news.stocktradersdaily.com
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers - The Globe and Mail
Tempus AI Surges 40% YTD: Are New Strategic Deals A Buy Signal? - Barchart
BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – IRTC - Business Wire
iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter - Yahoo Finance
iRhythm Technologies Inc (IRTC) Shares Gap Down to $83.555 on De - GuruFocus.com
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) - Barchart
When the Price of (IRTC) Talks, People Listen - news.stocktradersdaily.com
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Despite currently being unprofitable, iRhythm Technologies (NASDAQ:IRTC) has delivered a 28% return to shareholders over 5 years - Simply Wall St
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Principal Financial Group Inc. - Defense World
iRhythm Technologies, Inc. to Host Earnings Call - ACCESS Newswire
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stake Raised by Bank of New York Mellon Corp - Defense World
Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Pric - GuruFocus.com
Versor Investments LP Acquires Shares of 2,780 iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm technologies CEO sells $885,931 in stock By Investing.com - Investing.com India
Irhythm Technologies Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.81%
1.34%
자본화:
|
볼륨(24시간):